Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deemesh Oudit

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Human Genetics : EJHG|August 28, 2014
Common variants modify the age of onset for basal cell carcinomas in Gorlin syndromeBinnaz Yasar, Helen J Byers, Miriam J Smith, et al.
International Journal of Cancer|April 11, 2022
Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre studyBethan Clayton, Ferhan Muneeb, Maria Celia B Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Female Immunity Protects from Cutaneous Squamous Cell CarcinomaTimothy Budden, Caroline Gaudy-Marqueste, Sarah Craig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutationsMiriam J Smith, Christian Beetz, Simon G Williams, et al.
Cancer Discovery|December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Human Genetics : EJHG|August 28, 2014
Common variants modify the age of onset for basal cell carcinomas in Gorlin syndromeBinnaz Yasar, Helen J Byers, Miriam J Smith, et al.
International Journal of Cancer|April 11, 2022
Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre studyBethan Clayton, Ferhan Muneeb, Maria Celia B Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Female Immunity Protects from Cutaneous Squamous Cell CarcinomaTimothy Budden, Caroline Gaudy-Marqueste, Sarah Craig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutationsMiriam J Smith, Christian Beetz, Simon G Williams, et al.
Cancer Discovery|December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Pageof 2